Share prices for Oncology Venture (OV)

Price information




Scheduled Reports

Annual General Meeting

Interim Report Q1

Half Year Report

Interim Report Q3

Year End Report

About company

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

  • CEO Peter Buhl Jensen
  • Chairm. of the Board Duncan Moore

Instrument Information

  • Full Name Oncology Venture
  • Short Name OV
  • No of shares 13 832 716
  • ISIN code SE0007157409
  • OrderBookID 4139
  • CFI (ISO 10962) ESVUFR
  • Liquidity Provider Sedermera Fondkommission
  • Par Value 0.14 kr
  • First Traded 22-07-2015
  • Type Share